AbbVie
ABBV
#25
Rank
A$568.39 B
Marketcap
$321.31
Share price
-0.73%
Change (1 day)
15.84%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of December 2024 : A$105.91 Billion

According to AbbVie's latest financial reports the company's total debt is A$105.91 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2024-12-31A$107.94 B23.85%
2023-12-31A$87.16 B-6.25%
2022-12-31A$92.97 B-12.1%
2021-12-31A$105.77 B-5.49%
2020-12-31A$111.91 B17.43%
2019-12-31A$95.30 B66.56%
2018-12-31A$57.22 B19.55%
2017-12-31A$47.86 B-6.35%
2016-12-31A$51.11 B17.56%
2015-12-31A$43.47 B137.56%
2014-12-31A$18.30 B10.87%
2013-12-31A$16.50 B9.45%
2012-12-31A$15.08 B32114.79%
2011-12-31A$46.81 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$100.40 B-5.21%๐Ÿ‡บ๐Ÿ‡ธ USA
A$80.76 B-23.75%๐Ÿ‡บ๐Ÿ‡ธ USA
A$53.07 B-49.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$94.80 B-10.49%๐Ÿ‡บ๐Ÿ‡ธ USA
A$42.13 B-60.22%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.45 B-90.13%๐Ÿ‡บ๐Ÿ‡ธ USA
A$33.62 B-68.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$47.50 B-55.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$0.71 B-99.32%๐Ÿ‡บ๐Ÿ‡ธ USA